Macrophages (labeled by F4/80 or CD68), especially Kupffer cells, which were considered as the key mediator of hepatic inflammation during NASH development (24, 25), were decreased by LOLA compared with those in vehicle-treated group (Figures 6C,F). Here, CD68 is linked to metabolic dysfunction-associated steatohepatitis.